Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2013 · 10-Q
Revenue$4.93B$4.93B−7.2% vs Q2 2012 Net Income$476.00M$476.00M−72.4% vs Q2 2012 EPS Diluted$0.30$0.30−72.2% vs Q2 2012 Gross Profit$2,429,000,000−11.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$717,000,000−65.3% Free Cash Flowderived$426,000,000−74.1% Margins · derivedGross margin49.2%−2.5 pt vs Q2 2012
Operating margin12.7%+2.1 pt vs Q2 2012
Net margin9.6%−22.8 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 6, 2013 · 37 d after period end